Cargando…

HMGB1, a new proinflammatory molecule of interest in polymyositis and dermatomyositis patients

Detalles Bibliográficos
Autores principales:	Grundtman, C, Ulfgren, A-K, Borg, K, Andersson, U, Erlandsson-Harris, H, Lundberg, IE
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833654/ http://dx.doi.org/10.1186/ar717

Ejemplares similares

HMGB1 is a potent proinflammatory mediator expressed abundantly in chronic synovitis
por: Andersson, UG, et al.
Publicado: (2002)

Intra-articular steroid treatment reduces synovial HMGB1 but not IL-1 expression in chronic arthritis
por: Grundtman, C, et al.
Publicado: (2004)

Covariation of MHC class I and CD163 positive macrophages in skeletal muscle tissue of polymyositis and dermatomyositis patients after treatment with high-dose intravenous immunoglobulin (IVIg)
por: Barbasso, S, et al.
Publicado: (2003)

Nutrition and Polymyositis and Dermatomyositis
por: Loell, Ingela, et al.
Publicado: (2008)

Vascular endothelial growth factor (VEGF) expression in muscle tissue and the effect of corticosteroid therapy in patients with poly- and dermatomyositis
por: Lundberg, IE
Publicado: (2002)

Systemic TNF blockade does not modulate synovial expression of the pro-inflammatory mediator HMGB1 in rheumatoid arthritis patients – a prospective clinical study
por: Sundberg, Erik, et al.
Publicado: (2008)

Effects of immunosuppressive treatment on microsomal prostaglandin E synthase 1 and cyclooxygenases expression in muscle tissue of patients with polymyositis or dermatomyositis
por: Korotkova, M, et al.
Publicado: (2008)

Differential gene expression and protein expression levels of MMP and TIMP molecules in response to glucocorticoid treatment in arthritic patients
por: Andersson, T, et al.
Publicado: (2004)

Viral Etiology of Polymyositis/Dermatomyositis
por: DENMAN, A.M.
Publicado: (1988)

Subcutaneous Edema in Polymyositis and Dermatomyositis
por: Yoshimi, Ryusuke, et al.
Publicado: (2023)

Heterogeneity in cytokine profile after intra-articular steroid treatment
por: AfKlint, ENG, et al.
Publicado: (2002)

HMGB1 May Be a Biomarker for Predicting the Outcome in Patients with Polymyositis /Dermatomyositis with Interstitial Lung Disease
por: Shu, Xiaoming, et al.
Publicado: (2016)

Dynamics of early synovial cytokine expression in rodent collagen-induced arthritis: a therapeutic study
por: Palmblad, K, et al.
Publicado: (2001)

Polymyositis and dermatomyositis: Disease spectrum and classification
por: Raychaudhuri, Siba P, et al.
Publicado: (2012)

Polymyositis and dermatomyositis – challenges in diagnosis and management
por: Yang, Shu-Han, et al.
Publicado: (2019)

Dermatomyositis and polymyositis in total hip arthroplasty
por: Rosas, Samuel, et al.
Publicado: (2021)

Acute polymyositis associated with hemophagocytic lymphohistiocytosis syndrome
por: Karjigi, Uma, et al.
Publicado: (2013)

Polymyositis and dermatomyositis as a risk of developing cancer
por: Jakubaszek, Michał, et al.
Publicado: (2015)

Cardiac involvement in polymyositis and dermatomyositis: diagnostic approaches
por: Trybuch, Agnieszka, et al.
Publicado: (2023)

Circulating plasma microRNA profiling in patients with polymyositis/dermatomyositis before and after treatment: miRNA may be associated with polymyositis/dermatomyositis
por: Hirai, Takuya, et al.
Publicado: (2018)

Potential role of autophagy in T-cell survival in polymyositis and dermatomyositis
por: Shu, Xiaoming, et al.
Publicado: (2017)

Citrullinated proteins in arthritis: presence in joints and effects on immunogenicity
por: Lundberg, K, et al.
Publicado: (2004)

T-cell transcriptomics from peripheral blood highlights differences between polymyositis and dermatomyositis patients
por: Houtman, Miranda, et al.
Publicado: (2018)

Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis
por: Raouf, Joan, et al.
Publicado: (2018)

Marked expression of IL-1 receptors in cell nuclei and muscle fiber membrane in muscle tissue of patients with idiopathic inflammatory myopathies
por: Grundtman, C, et al.
Publicado: (2005)

Hyaluronic acid in dermatomyositis and polymyositis: relationship with disease and cutaneous lesions
por: Silva, Marilda Guimarães, et al.
Publicado: (2018)

STROBE: The correlation of Cyr61, CTGF, and VEGF with polymyositis/dermatomyositis
por: Chai, Ke-Xia, et al.
Publicado: (2018)

Identification of hub biomarkers and immune cell infiltration in polymyositis and dermatomyositis
por: Chen, Si, et al.
Publicado: (2022)

Randomized Trial of Tocilizumab in the Treatment of Refractory Adult Polymyositis and Dermatomyositis
por: Oddis, Chester V., et al.
Publicado: (2022)

Proinflammatory impact of norepinephrine in cardiomyocytes: increased interleukin-6 production, which is suppressed by carvedilol
por: Müller-Werdan, U, et al.
Publicado: (1999)

Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan
por: Chen, Yi-Ju, et al.
Publicado: (2010)

Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis
por: Kim, Geun-Tae, et al.
Publicado: (2009)

The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
por: Sugiyama, Yumiko, et al.
Publicado: (2018)

Upregulation of Interleukin 21 and Interleukin 21 Receptor in Patients with Dermatomyositis and Polymyositis
por: Liu, Tao, et al.
Publicado: (2017)

Epilepsy as a Comorbidity in Polymyositis and Dermatomyositis—A Cross-Sectional Study
por: Nissan, Ella, et al.
Publicado: (2021)

Supervised Physical Therapy and Polymyositis/Dermatomyositis—A Systematic Review of the Literature
por: Corrado, Bruno, et al.
Publicado: (2020)

Clinical Features of Dermatomyositis/Polymyositis with Anti-MDA5 Antibody Positivity
por: Chen, Qiuhe, et al.
Publicado: (2022)

Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis
por: Palmucci, Stefano, et al.
Publicado: (2022)

Serum uric acid is independently associated with hypertension in patients with polymyositis and dermatomyositis
por: liu, mei, et al.
Publicado: (2023)

Increased apoptosis level in late stages of rheumatoid arthritis correlates with macrophage number
por: Catrina, AI, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_74pfkqkjbun6dj144vfl16b5jg